Vanguard Group Inc Zentalis Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,612,707 shares of ZNTL stock, worth $16.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,612,707

Previous 5,654,757 18.43%

Holding current value

$16.9 Million

Previous $23.1 Million 26.8%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.9 - $4.57 $3.02 Million - $4.76 Million	-1,042,050 Reduced 18.43%	4,612,707 $16.9 Million
Q2 2024 Aug 13, 2024	BUY	$4.09 - $16.13 $5.14 Million - $20.3 Million	1,256,132 Added 28.56%	5,654,757 $23.1 Million
Q1 2024 May 10, 2024	SELL	$10.83 - $16.49 $10.3 Million - $15.7 Million	-951,833 Reduced 17.79%	4,398,625 $69.3 Million
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $1.12 Million - $2.29 Million	113,795 Added 2.17%	5,350,458 $81.1 Million
Q3 2023 Nov 14, 2023	BUY	$19.63 - $28.29 $6.04 Million - $8.7 Million	307,490 Added 6.24%	5,236,663 $105 Million
Q2 2023 Aug 14, 2023	BUY	$17.41 - $30.05 $12 Million - $20.7 Million	688,558 Added 16.24%	4,929,173 $139 Million
Q1 2023 May 15, 2023	BUY	$16.14 - $24.94 $1.3 Million - $2.01 Million	80,466 Added 1.93%	4,240,615 $72.9 Million
Q4 2022 Feb 10, 2023	BUY	$18.07 - $25.6 $973,756 - $1.38 Million	53,888 Added 1.31%	4,160,149 $83.8 Million
Q3 2022 Nov 14, 2022	SELL	$20.23 - $31.73 $7.81 Million - $12.3 Million	-386,074 Reduced 8.59%	4,106,261 $88.9 Million
Q2 2022 Aug 12, 2022	BUY	$17.91 - $52.25 $22.4 Million - $65.4 Million	1,251,750 Added 38.63%	4,492,335 $126 Million
Q1 2022 May 13, 2022	BUY	$41.58 - $80.89 $2.23 Million - $4.34 Million	53,599 Added 1.68%	3,240,585 $150 Million
Q4 2021 Feb 14, 2022	BUY	$66.92 - $84.79 $3.69 Million - $4.67 Million	55,101 Added 1.76%	3,186,986 $268 Million
Q3 2021 Nov 12, 2021	BUY	$46.83 - $73.5 $13.9 Million - $21.8 Million	297,061 Added 10.48%	3,131,885 $209 Million
Q2 2021 Aug 13, 2021	BUY	$37.41 - $62.25 $106 Million - $176 Million	2,834,824 New	2,834,824 $151 Million

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $209M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Zentalis Pharmaceuticals, Inc. Transaction History